Susquehanna International Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.5M | Sell |
467,800
-310,500
| -40% | -$9.25M | ﹤0.01% | 2527 |
|
|
2025
Q4 | $23.2M | Sell |
778,300
-30,200
| -4% | -$986K | ﹤0.01% | 2050 |
|
|
2025
Q3 | $29.2M | Buy |
808,500
+183,300
| +29% | +$6.04M | ﹤0.01% | 1815 |
|
|
2025
Q2 | $22.5M | Sell |
625,200
-32,800
| -5% | -$1.22M | ﹤0.01% | 1884 |
|
|
2025
Q1 | $25.9M | Sell |
658,000
-616,200
| -48% | -$20.7M | ﹤0.01% | 1511 |
|
|
2024
Q4 | $38.4M | Buy |
1,274,200
+435,800
| +52% | +$12.5M | 0.01% | 1314 |
|
|
2024
Q3 | $19.6M | Buy |
838,400
+127,100
| +18% | +$2.78M | ﹤0.01% | 1853 |
|
|
2024
Q2 | $12.7M | Sell |
711,300
-166,300
| -19% | -$2.65M | ﹤0.01% | 2204 |
|
|
2024
Q1 | $13.3M | Sell |
877,600
-323,400
| -27% | -$5.15M | ﹤0.01% | 2235 |
|
|
2023
Q4 | $20.5M | Buy |
1,201,000
+180,000
| +18% | +$2.09M | ﹤0.01% | 1786 |
|
|
2023
Q3 | $8.54M | Buy |
1,021,000
+59,900
| +6% | +$835K | ﹤0.01% | 2763 |
|
|
2023
Q2 | $23.9M | Buy |
961,100
+333,200
| +53% | +$8.61M | ﹤0.01% | 1559 |
|
|
2023
Q1 | $9.44M | Sell |
627,900
-240,200
| -28% | -$3.65M | ﹤0.01% | 2535 |
|
|
2022
Q4 | $10.3M | Buy |
868,100
+454,500
| +110% | +$3.3M | ﹤0.01% | 2237 |
|
|
2022
Q3 | $2.45M | Buy |
413,600
+59,900
| +17% | +$393K | ﹤0.01% | 4515 |
|
|
2022
Q2 | $1.5M | Sell |
353,700
-54,000
| -13% | -$337K | ﹤0.01% | 5533 |
|
|
2022
Q1 | $3.88M | Buy |
407,700
+48,300
| +13% | +$559K | ﹤0.01% | 4125 |
|
|
2021
Q4 | $6.83M | Buy |
359,400
+45,900
| +15% | +$1.19M | ﹤0.01% | 3239 |
|
|
2021
Q3 | $10.4M | Buy |
313,500
+41,500
| +15% | +$1.28M | ﹤0.01% | 2803 |
|
|
2021
Q2 | $10.6M | Sell |
272,000
-81,200
| -23% | -$3.19M | ﹤0.01% | 2845 |
|
|
2021
Q1 | $17M | Sell |
353,200
-28,100
| -7% | -$1.35M | ﹤0.01% | 2074 |
|
|
2020
Q4 | $19.8M | Buy |
381,300
+23,400
| +7% | +$791K | ﹤0.01% | 1746 |
|
|
2020
Q3 | $9.58M | Buy |
357,900
+118,900
| +50% | +$2.74M | ﹤0.01% | 2239 |
|
|
2020
Q2 | $4.66M | Buy |
239,000
+65,900
| +38% | +$1.06M | ﹤0.01% | 3101 |
|
|
2020
Q1 | $1.7M | Sell |
173,100
-44,100
| -20% | -$557K | ﹤0.01% | 4262 |
|
|
2019
Q4 | $2.41M | Buy |
217,200
+132,300
| +156% | +$1.01M | ﹤0.01% | 4019 |
|
|
2019
Q3 | $477K | Sell |
84,900
-76,200
| -47% | -$531K | ﹤0.01% | 7407 |
|
|
2019
Q2 | $1.39M | Sell |
161,100
-82,800
| -34% | -$626K | ﹤0.01% | 4933 |
|
|
2019
Q1 | $1.96M | Buy |
243,900
+190,200
| +354% | +$1.03M | ﹤0.01% | 3776 |
|
|
2018
Q4 | $220K | Sell |
53,700
-213,500
| -80% | -$1.06M | ﹤0.01% | 7567 |
|
|
2018
Q3 | $1.5M | Buy |
267,200
+39,600
| +17% | +$452K | ﹤0.01% | 4487 |
|
|
2018
Q2 | $2.99M | Sell |
227,600
-69,900
| -23% | -$961K | ﹤0.01% | 3384 |
|
|
2018
Q1 | $4.22M | Buy |
297,500
+96,000
| +48% | +$1.23M | ﹤0.01% | 2753 |
|
|
2017
Q4 | $1.65M | Buy |
201,500
+6,200
| +3% | +$54.2K | ﹤0.01% | 4263 |
|
|
2017
Q3 | $2.31M | Buy |
195,300
+17,600
| +10% | +$200K | ﹤0.01% | 3643 |
|
|
2017
Q2 | $1.79M | Buy |
177,700
+59,700
| +51% | +$668K | ﹤0.01% | 4112 |
|
|
2017
Q1 | $1.38M | Buy |
118,000
+69,700
| +144% | +$500K | ﹤0.01% | 4459 |
|
|
2016
Q4 | $225K | Buy |
48,300
+13,900
| +40% | +$81.5K | ﹤0.01% | 8484 |
|
|
2016
Q3 | $266K | Sell |
34,400
-1,100
| -3% | -$7.08K | ﹤0.01% | 7129 |
|
|
2016
Q2 | $215K | Sell |
35,500
-54,500
| -61% | -$443K | ﹤0.01% | 7495 |
|
|
2016
Q1 | $767K | Buy |
90,000
+22,400
| +33% | +$196K | ﹤0.01% | 5614 |
|
|
2015
Q4 | $806K | Buy |
67,600
+30,500
| +82% | +$385K | ﹤0.01% | 5848 |
|
|
2015
Q3 | $374K | Sell |
37,100
-91,500
| -71% | -$1.36M | ﹤0.01% | 7653 |
|
|
2015
Q2 | $2.13M | Buy |
128,600
+6,500
| +5% | +$103K | ﹤0.01% | 4583 |
|
|
2015
Q1 | $1.89M | Buy |
122,100
+92,200
| +308% | +$1.4M | ﹤0.01% | 4422 |
|
|
2014
Q4 | $474K | Sell |
29,900
-44,300
| -60% | -$577K | ﹤0.01% | 7309 |
|
|
2014
Q3 | $792K | Sell |
74,200
-6,200
| -8% | -$57.5K | ﹤0.01% | 6385 |
|
|
2014
Q2 | $755K | Buy |
80,400
+61,300
| +321% | +$392K | ﹤0.01% | 6650 |
|
|
2014
Q1 | $132K | Buy |
19,100
+5,600
| +41% | +$33.1K | ﹤0.01% | 8476 |
|
|
2013
Q4 | $53K | Buy |
+13,500
| New | +$54.5K | ﹤0.01% | 8786 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
Susquehanna International Group's TGTX Position: Q1 2026 in Review
Susquehanna International Group reduced its TG Therapeutics (TGTX) stake by 39% in Q1 2026, selling an estimated $10.2M and leaving 544,720 shares worth $18.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2356.
Susquehanna International Group first reported a position in TGTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $55.7M in Q2 2021. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- Susquehanna International Group held 544,720 shares of TG Therapeutics worth $18.1M as of Q1 2026.
- Susquehanna International Group sold 342,731 TG Therapeutics shares in Q1 2026, an estimated $10.2M.
- TG Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2356 holding.
- Susquehanna International Group first reported a position in TG Therapeutics in Q2 2013 and has held it in 49 quarters since.
- Susquehanna International Group's TG Therapeutics position peaked at $55.7M in Q2 2021.
- 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.